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thoracoabdominal aorta. The incidence of spinal cord
complications ranges from 8% to 30% and depends on
the nature and extent of the disease and the duration of
aortic crossclamping or hypothermic circulatory arrest.1,2
Little is known about the exact mechanisms of neuronal
cell death after spinal cord ischemia, and several attempts
have been made experimentally and clinically to mini-
mize or prevent paraplegia after such operations.3-8
Evidence is gathering that excitatory amino acid
neurotransmission may contribute to neuronal cell
death.9,10 Glutamate, the most important excitatory
amino acid, is potentially toxic to central nervous tissue
through activation of postsynaptic N-methyl-D-aspar-
tate (NMDA) receptors and the subsequent induction of
excessive calcium ion influx, which leads to neuronal
cell death.11 NMDA antagonists have been proved to
reduce spinal cord injury after ischemia.12
P araplegia caused by ischemic injury or postischemicreperfusion injury remains an unpredictable compli-
cation after operations on the descending thoracic or
Background: This study was conducted to investigate the effect of
memantine, a noncompetitive N-methyl-D-aspartate receptor antago-
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thetized and spinal cord ischemia was induced for 40 minutes by
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tion, group 2 (n = 8) received intra-aortic memantine infusion (20
mg/kg) after aortic crossclamping, and group 3 (n = 8) was treated with
systemic memantine infusion (20 mg/kg) 45 minutes before aortic occlu-
sion. Neurologic status was scored by the Tarlov system (in which 4 is
normal and 0 is paraplegia) at 12, 24, 36, and 48 hours after the opera-
tion. Lumbar spinal root stimulation potentials and motor evoked
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after the operation. After the animals were killed, the spinal cords were
studied histopathologically. Results: All potentials disappeared shortly
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treated groups than in the placebo group. Histologic examination of
spinal cords revealed a few abnormal motor neurons in memantine-
treated rabbits but found extensive injury in the control group. At 12
hours the median Tarlov scores were 0 in the control group (group 1), 2
in the intra-aortic memantine group (group 2, P = .001 versus control),
and 3 in the systemic group (group 3, P = .0002 versus control). At 24
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significantly reduced neurologic injury related to spinal cord ischemia
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MEMANTINE FOR PREVENTION OF SPINAL CORD INJURY IN A RABBIT MODEL
The noncompetitive NMDA receptor antagonist
memantine is known to attenuate hypoxic or ischemic
damage to spinal neurons.13 This study elucidates the
effect of memantine on the neurologic outcome of
spinal cord ischemia and reperfusion injury related to
aortic occlusion in the rabbit model. The rabbit was
used because of its unique segmental arterial blood
supply to the spinal cord from the infrarenal aorta.14
The primary interest was to compare each treated group
with the control group.
Materials and methods
All animals received humane care in compliance with the
“Guide for the Care and Use of Laboratory Animals” pre-
pared by the Institute of Laboratory Animal Resources and
published by the National Institutes of Health (NIH
Publication No. 85-23, revised 1985) and “Guidelines for
Animal Experiment,” Vienna University Hospital.
Twenty-four New Zealand White rabbits (3.4-4.3 kg) were
randomly split into 3 groups. In the control group of 8 ani-
mals (group 1), crossclamping of the infrarenal aorta was per-
formed without intervention. In 8 rabbits (group 2) a 24-
gauge catheter was inserted into the aorta distal to the
proximal clamp and memantine was infused with an infusion
pump (20 mg/kg memantine in 15 mL sodium chloride at 5
mL/min) into the isolated aortic segment. After the infusion
the aortic catheter was removed and the arteriotomy was
closed with a 7-0 polypropylene suture. The third group
included 8 animals (group 3) that were treated with a sys-
temic memantine infusion (20 mg/kg memantine in 30 mL
sodium chloride at 1 mL/min) 45 minutes before aortic occlu-
sion. All animals were anesthetized intramuscularly with 25
mg/kg ketamine, 2.5 mg/kg xylazine, and 0.06 mg/kg
atropine.
After intubation, controlled ventilation (Servo 900;
Siemens-Elema, Solna, Sweden) was started with 8 mL/kg of
50% oxygen mixed with air at a respiratory rate of 30
breaths/min. Ketamine was infused at a rate of 4 to 6 mg ·
kg–1 · h–1 during the operation and was discontinued immedi-
ately after the procedure. An arterial line was placed in an ear
artery through a 22-gauge catheter for on-line monitoring of
arterial blood pressure. Arterial blood PO2, PCO2, pH, bicar-
bonate concentration, hemoglobin concentration, and hemat-
ocrit were measured every 15 minutes for the purpose of
adjusting ventilation to maintain a PCO2 of 36 ± 6 mm Hg.
Blood pressure, electrocardiogram, and rectal temperature
were recorded digitally (Hellige/Biosys, Vienna, Austria)
during the intervention. A heating pad was used on each ani-
mal to maintain normal body temperature.
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Table I. Neurologic status (Tarlov score) at 12, 24, 36, and 48 hours after aortic occlusion
12 h 24 h 36 h 48 h
Group Median Range Median Range Median Range Median Range
Control (n = 8) 0 0-1 0 0-1 0 0-2 0 0-2
Intra-aortic memantine (n = 8) 2* 0-3 2.5† 1-4 3‡ 1-4 3‡ 1-4
Systemic memantine (n = 8) 3† 2-4 4† 3-4 4† 3-4 4† 3-4
Tarlov score: 0, No movement; 1, slight movement; 2, sits alone; 3, weak hop; 4, normal hop.
*P = .001 versus control.
†P = .0002 versus control.
‡P = .0006 versus control.
Table II. Time for reduction of amplitudes of spinal root–stimulated muscle potentials after crossclamping compared
with baseline values taken 1 minute before occlusion of the aorta
Time until amplitude <75% (min) Time until amplitude <50% (min) Time until amplitude <25% (min)
Muscle I Muscle II Muscle III Muscle I Muscle II Muscle III Muscle I Muscle II Muscle III
Group 1
Median 13 14 16 23 15 16 26 16 23
Range 9-38 2-25 1-28 10-29 9-31 2-30 10-35 14-37 16-40
Group 2
Median 18 15 13 19 16 14 23 19 16
Range 7-36 1-40 5-27 9-24 1-40 5-33 11-26 1-40 5-40
Group 3
Median 18 14 14 19 14 15 22 15 20
Range 1-26 9-18 5-18 15-29 10-23 6-21 15-35 11-21 8-30
Muscle I, Superficial gluteal muscle; Muscle II, quadriceps muscle of the thigh; Muscle III, biceps muscle of the thigh; Group 1, control (n = 8); Group 2, animals
treated with memantine infusion during aortic crossclamping (n = 8); group 3, animals treated with systemic memantine infusion before crossclamping (n = 8). No
statistically significant difference was found between groups (P > .9) or between muscles (P = .14).
Motor evoked potentials. Two needle electrodes of an
electric stimulator (Digitimer A, Welwyn Garden City,
United Kingdom) for transcranial stimulation were fixed into
the scalp on the dorsum of the nose and the midline over the
occiput (anode). Additional electrodes of a second stimulator
(Digitimer) for spinal stimulation were placed into 2 dorsal
muscles on the left side close to lumbar vertebra 4 and spinal
vertebra 3. A 4-channel electromyograph (Viking IV, Nicolet,
Madison, Wis) was prepared for simultaneous recording of
compound muscle action potentials from the superficial
gluteal muscle, quadriceps muscle of the thigh, and biceps
muscle of the thigh. Two separate single-impulse stimula-
tions (150 m s) were released every minute, starting 2 minutes
before crossclamping and ending when anesthesia was fin-
ished. Output levels for single-impulse stimulation up to 160
V for transcranial stimulation and 70 V for spinal stimulation
were sufficient to achieve supramaximal stimulus; resulting
amperage was 50 to 150 mA. Intervals for amplitude change
(decrease or increase) by 75%, 50%, and 25% (with respect
to the size of amplitudes gained 1 minute before crossclamp-
ing) were evaluated.
After sterile preparation a median laparotomy was made.
The abdominal aorta was mobilized inferiorly to the left renal
vein and down to the bifurcation. Each rabbit had anticoagu-
lation with heparin (100 units/kg) before crossclamping.
Aortic occlusion was obtained by placement of a vascular
clamp above the aortic bifurcation followed by clamping of
the aorta just below the left renal vein. All animals were sub-
jected to 40 minutes of crossclamp time. Memantine was
obtained from Merz (Dr H. Kolassa and Merz, Vienna, Austria).
After 40 minutes, the crossclamps were released and the
laparotomy incision was closed. The animals were allowed to
recover. Neurologic status was assessed with the Tarlov score
(0, no movement; 1, slight movement; 2, sits alone; 3, weak
hop; 4, normal hop) at 12, 24, 36, and 48 hours after the oper-
ation by an observer who had no previous knowledge of the
experimental protocol.15
All animals were killed 48 hours after the operation with a
lethal injection of pentobarbital.
Histopathologic studies. All histopathologic materials
were examined by a neuropathologist (P.B.) who was blinded
both to the experimental design and to the identity of all ani-
mals. Excised segments of the vertebral column were fixed
by immersion in 5% neutralized formalin. The spinal medul-
la was dissected and specimens were divided into central and
external segments. Alcohol dehydration and paraffin embed-
ding were performed with a Tissue-Tek 2000 (Miles Lab-
oratories, Mishawaka, Ind) embedding device. Sections were
cut 5 m m thick and stained with hematoxylin and eosin.
Classification and quantification of anterior horn motor neu-
rons were done in sections stained with hematoxylin and
eosin. Perikarya were defined and counted and their frequen-
cies were compared between the groups. The following mor-
phologic criteria were used to define 4 groups of neurons: (1)
In neurons with normal morphologic characteristics,
perikarya are polygonal with cytoplasmic extensions.
Centrally positioned nuclei are round, well defined, with
loosely textured chromatin and prominent nucleolus. The
cytoplasm stains violet; it contains ample Nissl substance as
clumps of basophilic material. (2) In neurons with pyknosis,
cytoplasm of pyknotic motor neurons is condensed and clefts
separate the shrunken perikarya from the adjoining neuropil.
Nuclei are reduced in size and irregularly outlined. The cyto-
plasm of pyknotic neurons is hyperchromatic, and its color-
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Table III. Time for increase of amplitudes of spinal root–stimulated muscle potentials after release of crossclamp
compared with baseline values taken 1 minute before occlusion of the aorta
Time until amplitude >25% (min) Time until amplitude >50% (min) Time until amplitude >75% (min)
Muscle I Muscle II Muscle III Muscle I Muscle II Muscle III Muscle I Muscle II Muscle III
Group 1
Median 25 12 17 19 39 19 22 31 22
Range 25-34 1-27 3-18 9-28 4-47 1-23 4-39 25-33 4-29
Potentials* 3 3 7 3 3 6 3 3 4
Animals† 8 8 8 7 7 7 5 5 5
Group 2
Median 12 5 7 17 15 19 17 24 17
Range 4-40 3-26 1-10 14-19 3-30 3-24 17-17 3-35 10-27
Potentials* 5 4 5 4 4 4 1 3 3
Animals† 6 6 6 6 6 6 1 3 3
Group 3
Median 3 4 5 7 22 12 8 17 15
Range 1-11 2-18 2-8 1-26 18-28 4-27 1-15 17-17 2-28
Potentials* 5 5 4 4 3 3 3 1 3
Animals† 7 7 7 6 6 6 4 1 4
Muscle I, Superficial gluteal muscle; Muscle II, quadriceps muscle of the thigh; Muscle III, biceps muscle of the thigh; Group 1, control; Group 2, animals treated
with memantine infusion during aortic crossclamping; group 3, animals treated with systemic memantine infusion before crossclamping.
*Number of potentials that were recorded.
†Number of animals.
ing changes to eosinophilic. (3) In neurons with chromatoly-
sis, the perikaryon of chromatolytic motor neurons appears
enlarged, ovoid rather than polygonal in shape. Cytoplasmic
staining of these neurons is significantly reduced, causing an
overall pale appearance. (4) In neurons with vacuolization,
cellular shape is ovoid to round and Nissl substance is highly
dispersed or not present. In addition, the nucleus is heavily
disintegrated and largely devoid of chromatin.
Statistical analysis. Values are expressed as mean and SD
or as the median and range. The differences among groups in
Tarlov scores and in quantitative histologic findings were
tested by nonparametric statistical analysis with the Mann-
Whitney U test. Evoked potential data were analyzed with
repeated measurement analysis of variance on the log-trans-
formed data.
Results
All animals survived the procedure and were includ-
ed in the study. Differences among groups were not
found with respect to preoperative status, weight, tem-
perature, and heart rate. Control animals were para-
plegic with median Tarlov scores of 0 at all observation
points. One animal had a Tarlov score of 1 after 12
hours and improved to a score of 2 at 36 and 48 hours.
Twelve hours after the procedure, group 2 animals had
a median Tarlov score of 2, and 6 of 8 animals
improved to scores of 3 and 4 at 48 hours (median 3).
Preoperative systemic infusion of memantine in group
3 was associated with full recovery (Tarlov score 4) in
6 animals at 36 and 48 hours, with only 2 animals
reaching a score of 3 at the last 2 observation points.
Neurologic statuses at all 4 observation points are
depicted in Table I.
Motor evoked potentials. Transcranial evoked com-
pound muscle action potentials showed changes in
amplitudes before, during, and after crossclamping,
depending on the depth of anesthesia, and did not seem
useful for comparisons among the 3 groups. Most of
these amplitudes decreased at varied intervals, ranging
from a few minutes to the entire duration of cross-
clamping. When a bolus of anesthetic was given, com-
pound muscle action potentials disappeared. Spinal
evoked compound muscle action potentials of the
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Fig 1. Cross section of the lumbar spinal cord in an animal
treated with memantine. Well-preserved, normal-looking
motor neurons are seen. Perikarya are polygonal with cyto-
plasmic extensions. The cytoplasm stains violet; it contains
ample Nissl substance as clumps of basophilic material.
Fig 2. Cross section of the lumbar spinal cord in a control
animal. Edema and vacuolization are prominent in anterior
horn motor neurons. Cellular shape is ovoid to round, and
Nissl substance is highly dispersed or no longer present.
Table IV. Frequencies of intact and injured anterior horn motor neurons after 40 minutes of aortic crossclamping
Normal (%) Pyknotic (%) Chromatolytic (%) Vacuolization (%)
Group Median Range Median Range Median Range Median Range
Control (n = 8) 36 8-54 17.5 8-31 28 13-46 12 0-38
Intra-aortic memantine (n = 8) 69.5* 51-82 15.5 4-25 14.5 8-25 1† 0-7
Systemic memantine (n = 8) 63.5* 50-71 16 8-24 23 8-32 0 0-0‡
*P < .001 versus control.
†P = .015 versus control.
‡P = .002 versus control.
lower limb muscles did not depend on anesthetic con-
centration. During crossclamping all amplitudes de-
creased continuously, with no correlation in intervals
between the control animals and the treated groups
(Table II). Data on all observed sedated animals (6-8
animals until amplitude >25%, 6-7 animals until ampli-
tude >50%, and 1-5 animals until amplitude >75%)
indicate that both memantine groups regained some
activity of their potentials earlier than did the control
group after release of the clamp. Intervals for increase
of amplitude values by 25%, 50%, and 75% with
respect to baseline values gained 1 minute before cross-
clamping are depicted in Table III.
Histologic examination. When comparing anterior
horn, a predominance of well-preserved motor neurons
was found in groups 2 and 3, with only a few injured
neurons (Fig 1, Table IV). Edema and vacuolization
were prominent in animals to which no pharmacologic
intervention had been applied (Fig 2).
Discussion
Spinal cord injury and resultant paraplegia can be
devastating sequelae of operations on the descending
thoracic aorta. Despite various surgical and pharmaco-
logic efforts to minimize this complication, no method
has completely prevented the development of paraple-
gia. It appears that the cause of this complication is
multifactorial and includes prolonged duration of
ischemia, interruption of critical intercostal and lumbar
arteries, decrease in spinal cord perfusion pressure, and
postoperative reperfusion injury.16,17 There is evidence
that excitatory amino acid neurotoxicity may play a
role in neuronal injury after ischemia.9 Glutamate and
aspartate are 2 of these excitatory amino acid neuro-
transmitters. They bind to NMDA receptors, which are
abundant in the spinal cord.18 When stimulated the
NMDA receptors open a cation channel, allowing the
influx of calcium and sodium. Under physiologic cir-
cumstances, protective mechanisms limit neuronal glu-
tamate exposure and prevent toxicity. During hypoxia
energy failure disturbs ion hemostasis in the context of
glutamate accumulation. This accumulation may cause
neuronal overreaction and cell death. Pharmacologic
blockade of these receptors has been shown to decrease
spinal cord injury.19
This study demonstrates the efficacy of memantine in
reducing the neurologic injury associated with pro-
longed aortic occlusion. The neuroprotective potency
of this drug is presumably attributable to its ability to
block calcium ion entry into the cell.20
There was significant improvement in the clinical
outcomes of rabbits that received memantine with
respect to the control group. Both treated groups had
higher Tarlov scores than did the control animals. Six
of 8 animals treated with memantine before the opera-
tion had 100% recovery at 48 hours. These animals
were standing without difficulty and were hopping nor-
mally. Animals that received intra-aortic memantine
injections reached a median Tarlov score of 3 after 48
hours, without standing problems but with weak hop-
ping. In contrast, control animals were paraplegic dur-
ing the entire observation interval. Our results confirm
the findings of Keilhoff and colleagues21 that meman-
tine is probably most efficient when applied before sur-
gical intervention.
Histologic examination confirmed the ability of
memantine to limit neuronal necrosis in the anterior
horn motor neurons. Ischemia of the spinal cord in this
experiment caused perikaryal swelling and vacuoliza-
tion of anterior horn motor neurons. These morpholog-
ic changes developed after ischemia and caused the
physiologic and clinical consequences observed after
ischemic disturbance. Chromatolysis of Nissl sub-
stance, swelling and vacuolization of perikarya, and
karyolysis were more frequently seen in the control
group than in either group of treated animals, and these
control animals showed severe functional impairment.
For monitoring nerve conductance ability, cortical
somatosensory evoked potentials and different kinds of
motor evoked potentials have been used as an addition-
al method of detecting ischemia in an early and
reversible stage to allow application or adjustment of
protective strategies. Somatosensory evoked potentials
are conducted mainly in the ascending sensory tracts of
the posterior columns. Because the anterior horn motor
neurons are especially sensitive to ischemia and receive
their blood supply mainly from the anterior spinal
artery, whereas the posterior columns are supplied
through the posterior spinal artery, somatosensory
evoked potentials may not always reflect ischemia of
the motor system.22 In our study spinal root stimulation
potentials and transcranial motor evoked potentials
were used. The latter showed gradual decrease under
aortic occlusion but instant loss of amplitude when a
bolus of ketamine, with or without xylazine, was ad-
ministered. Our findings of various myogenic responses
of transcranial motor evoked potentials depending on
anesthesia depth is confirmed by other studies, which
showed amplitudes of both transcranial motor evoked
potentials and somatosensory evoked potentials to be
affected by anesthetics.23
Spinal root stimulation was associated with stable
measurement conditions, allowing comparison of treat-
ment groups with the control animals. Differences in
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times for reduction in amplitude during ischemia were
not found among the 3 groups, indicating that loss of
these recorded potentials did not reflect postoperative
neurologic outcome. After release of the aortic cross-
clamp there was a trend in which both treated groups
regained activity somewhat earlier than did the control
group. Animals were only stimulated until the point at
which they started to awake, however, so not all ani-
mals were included in this observation. This limitation
precluded statistical analysis of these potentials.
Further clinical investigations are required to determine
the beneficial effects of memantine in preventing spinal
cord injury after operations on the descending aorta.
This NMDA blocker might be of interest because it is
clinically used for the therapy of various cerebral dis-
orders, such as Parkinson disease, spasticity, and chronic
brain syndrome.24
In conclusion, memantine significantly reduces the
neurologic injury related to spinal cord ischemia.
Although extrapolating the results to human beings is
premature, systemic infusion of memantine may prove
to be a simple yet effective means of spinal cord pro-
tection in descending thoracic and thoracoabdominal
aneurysm repair.
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Discussion
Dr Edward D. Verrier (Seattle, Wash). Can you go into
more detail on the role of excitatory amino acids in ischemia-
reperfusion injury? Is this phenomenon exclusive to neural
tissue, for instance? What is the molecular mechanism; how
does it work? Does it affect transcription or translation at the
molecular level, or is it effective by changing calcium?
Dr Ehrlich. It is a complex cascade when spinal cord
ischemia is induced. First the ischemia initiates the release of
excitatory amino acids, such as glutamate, aspartate, and
glycine, from axons into the extracellular space. Postsynaptic
NMDA receptors, especially for the amino acid glutamate,
are activated. As a consequence, calcium channels are opened
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that further activate a series of enzymes, leading eventually to
neuronal cell death.
Dr Pedro J. del Nido (Boston, Mass). One of the mecha-
nisms through which delayed neuronal injury occurs is apop-
tosis, and that can occur 48 to 72 hours after the original
insult. Did you look for evidence that this might actually be
occurring in the spinal cord tissue? Also, did you actually
look for glutamate concentration in the spinal cord fluid?
Dr Ehrlich. No, in this study we did not look specifically
at apoptosis as a mechanism of cell death. I am aware that
there is growing evidence, especially from Dr Kouchoukos’
group, that apoptosis is among the mechanisms of delayed
programmed cell death. With respect to glutamate concentra-
tions in the spinal cord, it was difficult to obtain liquid from
the spine in this animal model.
Dr Tadashi Omoto (Boston, Mass). Maybe it was 3 years
ago in The Annals of Thoracic Surgery that a Japanese
researcher from Fukuoka University reported on aortic cross-
clamping as long as 24 hours before, providing a late window
on the preconditioning side of aortic crossclamping. Is this
the same mechanism of excitatory amino acids? The research
background was that before 24 hours after the aortic cross-
clamping of the descending aorta they showed improvement
of the paraplegia. Do you think this mechanism will be simi-
lar to the excitatory amino acid cascade you described?
Dr Ehrlich. I cannot comment on this. We know from
recent studies that there is an increase in all excitatory amino
acids shortly after aortic occlusion. I am unsure of the influ-
ence preconditioning of the spinal cord could have on the
release of glutamate.
Dr Fred A. Crawford, Jr (Charleston, SC). You had 2
experimental groups, 1 in which memantine was adminis-
tered intra-aortically and 1 in which it was administered sys-
temically. Is there any possibility that the 2 routes of admin-
istration could be additive, if the drug were to be given both
ways at the same time?
Dr Ehrlich. Such a form of application could possibly be
more powerful in preventing spinal cord ischemia.
Dr Tatu Juvonen (Oulu, Finland). I have a question
regarding this molecule. Most of those glutamate receptor
blockers are known to be extremely neurotoxic and to have
serious side effects in clinical use. With respect to meman-
tine, are there any potential concerns about clinical use?
Dr Ehrlich. I think that this is an important question
because most of the excitatory amino acid blockers used so
far, such as dextrorphan and MK-801, are neurotoxic in high-
er doses. Memantine, however, is already clinically used
today in many countries as an antiparkinsonian drug. This
drug is therefore of enormous interest with respect to clinical
application for the future.
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